A recent study hints that by lowering accessbarriers to mammography, the governmentcould offset the tendency of uninsuredminority women to delay seeking medicalhelp, including mammography.
A recent study hints that by lowering access barriers to mammography, the government could offset the tendency of uninsured minority women to delay seeking medical help, including mammography.
University of North Carolina researchers looked at the correlation between the insurance status of 617 breast cancer patients and the stage and size of their tumors at the time of diagnosis. They found that uninsured non-Caucasian patients have a higher probability of presenting with a more advanced cancer stage and larger tumor size than insured patients. They published their results in Academic Radiology (2008;15[10]: 1255-1258). Dr.Wende Logan-Young, director of the Elizabeth Wende Breast Clinic in Rochester, NY, confirmed that uninsured minority women are less likely than other atrisk populations to undergo screening mammography. An effort by the Obama administration to cover uninsured U.S. residents could change this trend, she said.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.